Big Tech Promises an AI Breakthrough Against Cancer: The Promise Versus the Practice
In a new article, The Guardian examines the gap between tech companies' grand promises about AI and curing cancer, and what has actually been achieved in practice so far.
Promise Versus Reality
Artificial intelligence has been touted by major technology companies for years as a possible key to curing cancer. At the same time, those same companies and researchers warn of existential risks posed by AI, including scenarios in which the technology could harm humanity. Between these two extremes, journalist Jackson Ryan poses a simple but provocative question in The Guardian: if AI can cure cancer, then where is that cure?
The article, published on Tuesday, 22 September 2026, frames this question not only in a technological context but also in a personal one. Ryan opens with the story of his grandmother June, whom he calls 'Nan,' who died of cancer. The description of her final days — marked by liver failure and a body visibly overtaken by the disease — serves as a human counterweight to the grand language tech companies use to present their AI ambitions in healthcare.
What AI Is Already Doing
Although the article, according to the accompanying image caption, acknowledges that 'significant progress' has been made in using AI for cancer detection, prevention, and treatment, the emphasis is on how that progress compares to the grand claims regularly made by the industry. The available material does not further specify concrete breakthroughs, clinical results, or particular companies; the article appears to focus on the broader discrepancy between marketing language and measurable medical impact.
This discrepancy is not new. Criticism has long been voiced in scientific and journalistic circles about the way AI applications in healthcare are presented: promising algorithms that perform well under laboratory conditions, but whose actual deployment in hospitals and clinical pathways proceeds more slowly than the announcements suggest.
Tension Between Hope and Hype
Ryan's article ties into a broader societal discussion about the double message the tech sector sends out regarding AI: on one hand, alarming warnings about the risks of increasingly powerful systems, and on the other, lofty promises about what these systems could mean for humanity, from climate solutions to drug development.
For patients and their families — as illustrated by the personal story about June — this discussion is not abstract. The question of whether AI can genuinely save lives in the short term stands in stark contrast to the reality of disease progression and death that is already unfolding today, regardless of any technological promise.
Conclusion
The Guardian article does not yet offer a definitive answer to whether AI is actually bringing a cure for cancer within reach. It does, however, highlight a recurring tension: the gap between the grand words of tech companies and the slow, uneven reality of medical progress. Further reporting with concrete research findings and statements from experts involved remains to be seen.